Sermorelin Acetate – GH Release Research Peptide
$190.00
Sermorelin Research
• Synthetic GHRH (1-29) analog that stimulates the pituitary to release endogenous growth hormone in a more physiological, pulsatile manner
• Previously FDA-approved (as Geref) for diagnostic use and treatment of growth hormone deficiency in children
• Supports increased GH and IGF-1 levels, lean body mass, and sleep quality in research
• Preserves natural feedback mechanisms compared with exogenous HGH administration
Sermorelin is a synthetic 29-amino-acid analog corresponding to the N-terminal fragment of native growth-hormone-releasing hormone (GHRH 1–29). It binds pituitary GHRH receptors to stimulate endogenous, pulsatile GH secretion while preserving somatostatin-mediated negative feedback. Clinical studies demonstrate restoration of youthful GH secretory patterns, elevation of IGF-1, and modest gains in lean body mass, particularly in older adults or individuals with relative GH insufficiency.
